| Document Date: 2013-06-24 03:06:50
Open Document File Size: 240,81 KBShare Result on Facebook
City Reading / Bucharest / / Company OIE Reference Laboratory / / Country France / United States / Canada / New Zealand / / Event Bankruptcy / / Facility OIE Reference Laboratory / / IndustryTerm consistent site / mM solution / final product / vaccine product / real-time studies / rapid processing / serological tool / intermediate products / suitable test protocol / biological product / real-time monitoring / manufacturing process / / MedicalCondition ataxia / incoordination / intense pruritus / A. INTRODUCTION Aujeszky’s disease / productive infection / pseudorabies / strokes / pneumonia / secondary bacterial infections / complicated secondary infections / field infection / white spots / disease / product Aujeszky’s disease / severe neurological disorders / strain / AUJESZKY’S DISEASE SUMMARY Aujeszky’s disease / encephalomyelitis / sterility / Aujeszky’s disease / live Aujeszky’s disease / natural infection / rhinitis / clinical disease / disease virus / encephalitis / latent infections / infectious diseases / infection / Aujeszky’s disease Sterility / severe epileptiform-like seizures / pruritus / / MedicalTreatment antibiotics / vaccination / / Organization European Commission / European Union / / Person Van Rijn / Van Oirschot / / Product fungizone / penicillin / acetic acid / / Technology suitable test protocol / ELISA protocols / diagnostic tests / antibodies / Recombinant DNA / /
SocialTag |
NB: Ve rsion a dopted by the Worl d A ssembly of De legates of the OIE in May[removed]CHAPTER 2.1.2.